Safety Assessment of Drug Metabolites: Characterization of Chemically Stable Metabolites
- 8 November 2006
- journal article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 19 (12) , 1564-1569
- https://doi.org/10.1021/tx6002547
Abstract
Drug molecules are typically subjected to a variety of biotransformation reactions, and the metabolites formed through these reactions must be considered when conducting safety testing programs for new chemical entities. Metabolites that are chemically stable sometimes have pharmacological activity profiles similar to those of the parent compound but rarely have potent activity against off-target receptors that is unique relative to the parent profile. This fact argues for the thorough testing of drug metabolites for their pharmacological activity. It also argues for a significantly lower need for the thorough characterization and quantitation of stable metabolites not thought to substantially contribute to the pharmacodynamic effect. Given the tremendous resource requirements involved in the thorough characterization of drug metabolites, a more flexible, tiered approach to stable metabolite characterization would seem to provide the best utilization of resources while still allowing a complete evaluation of the toxicological profile of a new drug.Keywords
This publication has 10 references indexed in Scilit:
- Cytochrome P450s and other enzymes in drug metabolism and toxicityThe AAPS Journal, 2006
- Elucidating mechanisms of drug-induced toxicityNature Reviews Drug Discovery, 2005
- Role of Metabolism in Drug-Induced Idiosyncratic HepatotoxicityCritical Reviews in Toxicology, 2005
- Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and GemfibrozilThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Assessment of the Contributions of CYP3A4 and CYP3A5 in the Metabolism of the Antipsychotic Agent Haloperidol to Its Potentially Neurotoxic Pyridinium Metabolite and Effect of Antidepressants on the Bioactivation PathwayDrug Metabolism and Disposition, 2003
- Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfateToxicology, 2001
- Abuse of guaifenesin-containing medications generates an excess of a carboxylate salt of beta-(2-methoxyphenoxy)-lactic acid, a guaifenesin metabolite, and results in urolithiasisUrology, 1999
- Metabolism of Some “Second”– and “Fourth”–Generation Antidepressants: Iprindole, Viloxazine, Bupropion, Mianserin, Maprotiline, Trazodone, Nefazodone, and VenlafaxineCellular and Molecular Neurobiology, 1999
- Ketoconazole-induced hepatic phospholipidosis in the mouse and its association with de-N-acetyl ketoconazoleToxicology, 1994
- Amygdalin (Laetrile) Toxicity in RodentsPublished by American Medical Association (AMA) ,1980